Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Receivables: 2024

Historic Change in Receivables for CG Oncology (CGON) over the last 1 years, with Dec 2024 value amounting to $689,000.

  • CG Oncology's Change in Receivables rose 628.89% to $238,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $663,000, marking a year-over-year change of. This contributed to the annual value of $689,000 for FY2024, which is N/A change from last year.
  • As of FY2024, CG Oncology's Change in Receivables stood at $689,000.
  • Over the past 5 years, CG Oncology's Change in Receivables peaked at $689,000 during FY2024, and registered a low of $689,000 during FY2024.
  • Moreover, its 1-year median value for Change in Receivables was $689,000 (2024), whereas its average is $689,000.